Salvage anlotinib showed sustained efficacy in heavily pretreated EGFR wild-type lung adenocarcinoma: A case report and review of the literature

RATIONALE: Anlotinib has been proved to be effective in advanced refractory non-small cell lung cancer. PATIENT CONCERNS: A 47-year-old female non-smoker was admitted due to persistent chest tightness for a month. DIAGNOSES: Epidermal growth factor receptor (EGFR) wild-type advanced primary lung ade...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Lei, Wang, Xiang, Wu, Wen-Bin, Zhang, Miao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544372/
https://www.ncbi.nlm.nih.gov/pubmed/33031343
http://dx.doi.org/10.1097/MD.0000000000022707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544372/
https://www.ncbi.nlm.nih.gov/pubmed/33031343
http://dx.doi.org/10.1097/MD.0000000000022707

Ejemplares similares